Clinical TrialsSearch results
Number of results: 248
Recruiting
- A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged >=40 to <=85 Years With Chronic Obstructive Pulmonary Disease.
- Chronic Obstructive Pulmonary Disease
- Obara Kentaro
- 2026-02-09
Recruiting
- Study of lunsekimig (SAR443765) compared with placebo in adults with high-risk asthma
- Asthma
- Obara Kentaro
- 2025-09-22
Recruiting
- A study to assess the efficacy and safety of Empasiprubart versus IVIg in adults with Multifocal Motor Neuropathy
- Multifocal Motor Neuropathy
- Narita Takanori
- 2025-05-28
Recruiting
- Study on the safety of hydrogen inhalation in hemodialysis patients.
- Chronic kidney disease G5D (under hemodialysis)
- Shibuya Masaki
- 2025-03-07
Recruiting
- Post-marketing clinical study of AVIGAN tablets 200mg (SFTS)
- Severe Fever with Thrombocytopenia Syndrome
- PMS Management Supervisor
- 2024-12-17
Other
- Randomized Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Metastatic pancreatic ductal adenocarcinoma (mPDAC)
- Nasermoaddeli Ali
- 2024-11-14
Recruiting
- Progression Suppression and Retinal Regression in VEGF-resistant AMD
- Neovascular Age-related Macular Degeneration (AMD) that shows no response to existing therapy
- Kusano Hitoshi
- 2024-11-14
Recruiting
- A phase I trial of neoadjuvant DCF therapy for elderly esophageal cancer patients.
- Esophageal cancer
- Hiroaki Nagano
- 2024-10-08
Recruiting
- A Phase III, Randomised, Open-label, Global Study of Adjuvant Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma Non-small Cell Lung Cancer Who Are ctDNA-positive or Have High-risk Pathological Features (TROPION-Lung12)
- Non-small Cell Lung Cancer
- Hibi Kazushige
- 2024-10-07
Recruiting
- A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Metastatic Non-small Cell Lung Cancer
- Hibi Kazushige
- 2024-09-03